Envista Holdings Corporation $NVST Shares Purchased by Cwm LLC

Cwm LLC boosted its stake in Envista Holdings Corporation (NYSE:NVST) by 55.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 72,217 shares of the company’s stock after buying an additional 25,905 shares during the period. Cwm LLC’s holdings in Envista were worth $1,568,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in NVST. Holocene Advisors LP acquired a new position in shares of Envista during the second quarter valued at $43,936,000. Alliancebernstein L.P. increased its holdings in shares of Envista by 34.0% during the second quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock valued at $119,164,000 after purchasing an additional 1,547,656 shares during the period. Balyasny Asset Management L.P. acquired a new position in shares of Envista during the third quarter valued at $24,260,000. Integral Health Asset Management LLC acquired a new position in shares of Envista during the third quarter valued at $11,204,000. Finally, Massachusetts Financial Services Co. MA increased its holdings in shares of Envista by 22.0% during the third quarter. Massachusetts Financial Services Co. MA now owns 2,905,149 shares of the company’s stock valued at $59,178,000 after purchasing an additional 523,949 shares during the period.

Wall Street Analysts Forecast Growth

NVST has been the topic of a number of research analyst reports. Robert W. Baird set a $30.00 price target on Envista in a report on Friday, February 6th. Wall Street Zen raised Envista from a “buy” rating to a “strong-buy” rating in a report on Monday, January 26th. Stifel Nicolaus set a $31.00 price target on Envista in a report on Friday, February 6th. Wells Fargo & Company raised their price target on Envista from $21.00 to $26.00 and gave the company an “equal weight” rating in a report on Friday, February 6th. Finally, Morgan Stanley raised their price target on Envista from $19.00 to $21.00 and gave the company an “equal weight” rating in a report on Friday. Seven research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat.com, Envista presently has an average rating of “Hold” and a consensus price target of $27.85.

Insider Transactions at Envista

In related news, SVP Mischa Reis sold 9,675 shares of Envista stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $30.00, for a total transaction of $290,250.00. Following the transaction, the senior vice president directly owned 32,382 shares of the company’s stock, valued at $971,460. The trade was a 23.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.99% of the stock is currently owned by insiders.

Envista Price Performance

NYSE:NVST opened at $26.84 on Friday. The business’s 50-day moving average price is $26.91 and its 200 day moving average price is $23.72. The firm has a market cap of $4.37 billion, a P/E ratio of 95.84, a PEG ratio of 1.85 and a beta of 0.98. Envista Holdings Corporation has a 52-week low of $15.49 and a 52-week high of $30.42. The company has a quick ratio of 2.04, a current ratio of 2.38 and a debt-to-equity ratio of 0.47.

Envista (NYSE:NVST) last released its earnings results on Thursday, February 5th. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.32 by $0.06. Envista had a return on equity of 6.54% and a net margin of 1.73%.The company’s quarterly revenue was up 15.0% compared to the same quarter last year. During the same quarter last year, the company earned $0.24 EPS. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. As a group, sell-side analysts predict that Envista Holdings Corporation will post 1.4 earnings per share for the current fiscal year.

Envista Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.